135 related articles for article (PubMed ID: 33655832)
1. Surface Engineering of Fenofibrate Nanocrystals Using Nano-by-Design Multivariate Integration: A Biopharmaceutical and Pharmacokinetic Perspective.
Gite S; Kakade P; Patravale V
Curr Drug Deliv; 2021; 18(9):1314-1329. PubMed ID: 33655832
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Performance Variables of Exemestane Nanosuspension Using Box-Behnken Design to Improve Dissolution and Oral Bioavailability.
Parmar K; Shah J
Curr Drug Deliv; 2021; 18(8):1148-1161. PubMed ID: 33438540
[TBL] [Abstract][Full Text] [Related]
3. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
Ige PP; Baria RK; Gattani SG
Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
[TBL] [Abstract][Full Text] [Related]
6. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.
Yang H; Teng F; Wang P; Tian B; Lin X; Hu X; Zhang L; Zhang K; Zhang Y; Tang X
Int J Pharm; 2014 Dec; 477(1-2):88-95. PubMed ID: 25455766
[TBL] [Abstract][Full Text] [Related]
7. A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies.
Narayan R; Pednekar A; Bhuyan D; Gowda C; Koteshwara KB; Nayak UY
Int J Nanomedicine; 2017; 12():4921-4935. PubMed ID: 28744125
[TBL] [Abstract][Full Text] [Related]
8. Comparison of media milling and microfluidization methods for engineering of nanocrystals: a case study.
Chogale M; Gite S; Patravale V
Drug Dev Ind Pharm; 2020 Nov; 46(11):1763-1775. PubMed ID: 32912040
[TBL] [Abstract][Full Text] [Related]
9. Increase in Dissolution Rate of Zotepine via Nanomilling Process - Impact of Dried Nanocrystalline Suspensions on Bioavailability.
Parmar K; Oza K
AAPS PharmSciTech; 2021 Dec; 23(1):20. PubMed ID: 34907489
[TBL] [Abstract][Full Text] [Related]
10. Development and Characterization of Venetoclax Nanocrystals for Oral Bioavailability Enhancement.
Kala SG; Chinni S
AAPS PharmSciTech; 2021 Mar; 22(3):92. PubMed ID: 33683477
[TBL] [Abstract][Full Text] [Related]
11. Significant progress in improving Atorvastatin dissolution rate: Physicochemical characterization and stability assessment of self-dispersible Atorvastatin/Tween 80® nanocrystals formulated through wet milling and freeze-drying.
Rossetti A; Real DA; Barrientos BA; Allemandi DA; Paredes AJ; Real JP; Palma SD
Int J Pharm; 2024 Jan; 650():123720. PubMed ID: 38110014
[TBL] [Abstract][Full Text] [Related]
12. Insight into the mechanism behind oral bioavailability-enhancement by nanosuspensions through combined dissolution/permeation studies.
Lynnerup JT; Eriksen JB; Bauer-Brandl A; Holsæter AM; Brandl M
Eur J Pharm Sci; 2023 May; 184():106417. PubMed ID: 36870578
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.
Karakucuk A; Celebi N
Pharm Res; 2020 May; 37(6):111. PubMed ID: 32476048
[TBL] [Abstract][Full Text] [Related]
14. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach.
Marzan AL; Tabassum R; Jahan B; Asif MH; Reza HM; Kazi M; Alshehri SM; de Matas M; Shariare MH
Curr Drug Deliv; 2018; 15(5):672-685. PubMed ID: 29359667
[TBL] [Abstract][Full Text] [Related]
16. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
17. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs.
Chai R; Gao H; Ma Z; Guo M; Fu Q; Liu H; He Z
Curr Drug Deliv; 2019; 16(6):500-510. PubMed ID: 31244438
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches.
Zhang H; Meng Y; Wang X; Dai W; Wang X; Zhang Q
Drug Deliv; 2014 Dec; 21(8):588-94. PubMed ID: 24320001
[TBL] [Abstract][Full Text] [Related]
20. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
Gajera BY; Shah DA; Dave RH
Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
